China PCI devices market is estimated to reach US$0.90 billion in 2023, growing at a CAGR of 11.61% for the period spanning from 2020 to 2024.

The factors such as increasing aging population, accelerating economic growth, rising prevalence of PCI, increasing healthcare expenditure, rising STEMI patients, growing obese population and increasing number of cardiac diseases are expected to drive the market.

Fill This Form and get the Sample Copy of This Report: https://www.sdki.jp/sample-request-62218


"The Final Report will cover the impact analysis of COVID-19 on this industry (China Coronary Intervention and Percutaneous Coronary Intervention Device Market)."

However, growth of the industry will be challenged by strict government regulations and risk of infection. A few notable trends include consumption of fast food, rising incidence of AMI and increasing demand for minimally invasive procedures.

PCI supporting devices include angiography guidewire, angiography catheter, guiding catheter, micro-guidewire, and inflation device.

Many types of supporting devices are needed during PCI procedure to deliver balloon catheters and stents to the blockage site.

Fill This Form and get the Sample Copy of This Report: https://www.sdki.jp/sample-request-62218


"The Final Report will cover the impact analysis of COVID-19 on this industry (China Coronary Intervention and Percutaneous Coronary Intervention Device Market)."

Rise in the number of qualified hospitals for PCI surgery and growing healthcare expenditure are likely to impact the PCI supporting devices demand in China.

Scope of the report:
• The report provides a comprehensive analysis of China CI & PCI devices market, segmented by origin into two segments: Domestic and International brands.
• The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
• The competitive landscape of the market, along with the company profiles of leading players (MicroPort Scientific Corporation, Lifetech Scientific Corporation, Terumo Corporation, Boston Scientific, Abbott Laboratories & Johnson & Johnson) are also presented in detail.

Key Target Audience:
• Device Manufacturers
• Raw Material/Component Suppliers
• End Users (Hospitals, Medical Centers & Clinical Institutes)
• Consulting Firms
• Investment Banks
• Government Bodies & Regulating Authorities



+ Table of Content +
1. Market Overview
1.1 Coronary Artery Disease (CAD)
1.2 CAD Diagnosis
1.3 CAD Treatment
1.4 Percutaneous Coronary Intervention (PCI)
1.5 Percutaneous Coronary Intervention (PCI) Procedure
1.6 Risks of Percutaneous Coronary Intervention (PCI)
1.7 PCI Supporting Devices
1.8 PCI Devices Used During Procedure
2. Market Analysis
2.1 China CI Device Market by Value
2.2 China CI Device Market Forecast by Value
2.3 China CI Device Market Share by Brand Origin
2.4 China CI Device International Brands Market
2.5 China CI Device International Brands Market Forecast
2.6 China CI Device Domestic Brands Market
2.7 China CI Device Domestic Brands Market Forecast
2.8 China CI Supporting Device Market by Category
2.9 China PCI Device Market by Value
2.10 China PCI Device Market Forecast by Value
2.11 China PCI Device Market Share by Brand Origin
2.12 China PCI Device International Brands Market
2.13 China PCI Device International Brands Market Forecast
2.14 China PCI Device Domestic Brands Market
2.15 China PCI Device Domestic Brands Market Forecast
2.16 China PCI Procedure
2.17 China PCI Procedure Forecast
2.18 China PCI Supporting Device Market by Category
2.19 China Stent Implantation per PCI Surgery
2.20 China Patients Type Treated by PCI Surgeries
2.21 China % of STEMI Patients with PPCI Treatment
2.22 China % of STEMI Patients with PPCI Treatment

For more market news and updates click here : https://sdki-blogs-market-news.blogspot.com